MoonLake Immunotherapeutics
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $8.1M | $76.8M | $39.5M |
| FY2023 | $13.0M | $526.5M | $451.2M |
| FY2024 | $24.5M | $477.9M | $180.4M |
| FY2025 | $120.0M | $424.4M | $334.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $8.1M | $76.8M | $39.5M |
| FY2023 | $13.0M | $526.5M | $451.2M |
| FY2024 | $24.5M | $477.9M | $180.4M |
| FY2025 | $120.0M | $424.4M | $334.5M |